Andy Harrison

CEO & General Partner

2021

Investment focus on AI, data and software applications in LLMs, data infrastructure, enterprise solutions, cybersecurity, quantum and computational biology. Board and observer rights in Ema, Cohere, Inceptive, Inworld, Stairwell, Phaidra, Gretel, BigHat and other leading companies. S32 is a venture capital firm investing at the frontiers of technology. Founded by Bill Maris, the team has vast experience building iconic companies. Our goal is to accelerate the discovery, development, and distribution of revolutionary technologies that improve the human condition. We invest across the entirety of technology. This includes artificial intelligence, enterprise software, cybersecurity, fintech, quantum computing and computational biology. Past private investments include Uber, Nest, Slack, Foundation Medicine, Thrive, Crowdstrike, Coinbase, 23andMe, Flatiron, Relay Tx and others.

Executive Leadership at X (GoogleX)

2020 - 2021

Advancing X projects, partnerships and strategic relationships in AI, data analytics, fintech, robotics, quantum computing, computational biology and other disciplines. Part of the teams that spun out SandboxAQ (www.sandboxaq.com) in the quantum computing space and Intrinsic (www.intrinsic.ai) in the AI and robotics space.

Global Head of Business & Corporate Development; Ventures Lead, Verily (Google Life Sciences)

2017 - 2020

I led a team that pioneered new partnership structures at the nexus of healthcare and artificial intelligence. As an executive and member of the leadership team, I executed >30 JVs, collaborations and strategic transactions. I helped raise billions in external capital and scaled Verily by greater than an order of magnitude. I was a part of the founding team of Granular Insurance (www.granularinsurance.com), a reinsurance subsidiary of Alphabet. As the leader of the business and corporate development team, I executed over a billion dollars of partnerships, collaborations, acquisitions, joint ventures and venture capital investments. My team also led go-to-market campaigns, including anchor partnerships for our artificial intelligence platforms. I co-founded Verily Ventures to support game-changing start ups. Verily Ventures produced top-tier financial performance. I represented Verily and Alphabet globally on a range of internal and external boards.

Managing Director, Chief Operating Officer

2016 - 2016

Founding institutional investor and the Managing Director and Chief Operating Officer of the firm. Led partnership and business development efforts and had an investment focus in the technology and healthcare sectors.

Managing Director, Head of Partnerships

2011 - 2015

Fintan Partners was a venture-backed investment firm seeded by Stanford University' endowment. I was responsible for all aspects of investing, portfolio management, product development and partnerships. I sat on the executive committee and investment committee, managed the investment team, established joint ventures and led new product development. I helped raise and deploy in excess of $1 billion in capital. Cantor Fitzgerald acquired the company in 2014.

Vice President, Portfolio Manager

2006 - 2011

Northwater Capital was a >$9 billion investment firm active in alternative investments and private markets (private equity, hedge funds and venture capital). I was a founding member of Northwater's venture capital program, scaling the program to >$600m with top tier global investors. The venture capital program invested in AI, healthcare technology, energy, SaaS and other technology investment areas. I also managed a portfolio >$1 billion invested in private equity and distressed credit.

Senior Associate

2002 - 2005

Member of the investment team of DFJ-Primaxis, which was a part of the Draper Fisher Jurvetson global network. I was also a member of the investment team of the RBC Strategic Investment Fund (now Information Ventures). I led investments in early stage companies in healthcare, networking, nanotechnology, fintech and big data.

Analyst

2000 - 2002